Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression
- PMID: 7535482
Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression
Abstract
A retrospective cohort study was conducted to determine the incidence of major infectious complications after orthotopic liver transplantation and to compare outcomes in patients receiving either cyclosporine (CsA) or FK506 (tacrolimus) as primary immunosuppression. Of 133 transplants performed in 118 patients, 124 transplant episodes were evaluated. Cytomegalovirus (CMV) infection (INF) and disease (DIS), deep fungal infection (DFI), and intraabdominal bacterial infections (IAI) were catalogued. The overall incidences of major infectious outcomes were: CMV INF = 33%; CMV DIS = 19%; DFI = 15%; and IAI = 25%. Cox proportional hazard analysis identified donor seropositivity, OKT3 as secondary immunosuppression and initial intensive care unit (ICU) duration as risk factors for CMV INF and DIS in the overall population. Fungal colonization was the dominant risk factor associated with deep fungal infection. A choledochojejunostomy anastomosis, the number of cellular blood products transfused at the time of transplantation surgery, and prior CMV INF were independent risk factors for both fungal colonization and deep infection. The single risk factor identified for intraabdominal bacterial infections was the number of cellular blood products transfused at the time of surgery. In the Cox proportional hazards model the relative risk (RR) for each category of infection was lower in the FK506 group (CMV: RR = .87, 95% confidence interval [C.I.] = [.32-2.4]; DFI: .58 [.13-2.6]; IAI: .51 [.15-1.7]), but the effect was not statistically significant. Survival was similar in patients receiving FK506 or CsA. CMV INF and DFI were independent predictors of death for all patients. Risk factors identified for CMV INF and DIS support the findings of others. Higher intraoperative blood product requirements and complicated intraoperative or postoperative courses increase the risk for IAI or DFI. The development of effective strategies to prevent CMV and fungal infections in liver transplant recipients remains a priority for future endeavors.
Similar articles
-
Who among cytomegalovirus-seropositive liver transplant recipients is at risk for cytomegalovirus infection?Liver Transpl. 2005 Jun;11(6):700-4. doi: 10.1002/lt.20417. Liver Transpl. 2005. PMID: 15915496
-
Risk factors associated with cytomegalovirus infection in orthotopic liver transplant patients.Transplant Proc. 2006 Jul-Aug;38(6):1922-3. doi: 10.1016/j.transproceed.2006.06.075. Transplant Proc. 2006. PMID: 16908324
-
Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease.Biol Blood Marrow Transplant. 2007 Dec;13(12):1487-98. doi: 10.1016/j.bbmt.2007.08.049. Biol Blood Marrow Transplant. 2007. PMID: 18022579 Clinical Trial.
-
Bacterial pneumonia in solid organ transplantation.Semin Respir Infect. 1990 Mar;5(1):10-29. Semin Respir Infect. 1990. PMID: 2188317 Review.
-
Infectious complications in the early postoperative period in liver transplant patients.Minerva Gastroenterol Dietol. 2010 Sep;56(3):355-65. Minerva Gastroenterol Dietol. 2010. PMID: 21037551 Review.
Cited by
-
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.Clin Infect Dis. 2009 Mar 1;48(5):503-35. doi: 10.1086/596757. Clin Infect Dis. 2009. PMID: 19191635 Free PMC article.
-
Iron-related markers are associated with infection after liver transplantation.Liver Transpl. 2017 Dec;23(12):1541-1552. doi: 10.1002/lt.24817. Liver Transpl. 2017. PMID: 28703464 Free PMC article.
-
Is Routine Prophylaxis Against Pneumocystis jirovecii Needed in Liver Transplantation? A Retrospective Single-Centre Experience and Current Prophylaxis Strategies in Spain.J Clin Med. 2020 Nov 6;9(11):3573. doi: 10.3390/jcm9113573. J Clin Med. 2020. PMID: 33171962 Free PMC article.
-
Fungal Infections in Liver Transplant Recipients.J Fungi (Basel). 2021 Jun 29;7(7):524. doi: 10.3390/jof7070524. J Fungi (Basel). 2021. PMID: 34210106 Free PMC article. Review.
-
Infections in solid-organ transplant recipients.Clin Microbiol Rev. 1997 Jan;10(1):86-124. doi: 10.1128/CMR.10.1.86. Clin Microbiol Rev. 1997. PMID: 8993860 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical